Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Change in Inventory: 2018-2019

Historic Change in Inventory for Aclaris Therapeutics (ACRS) over the last 2 years, with Dec 2019 value amounting to -$605,000.

  • Aclaris Therapeutics' Change in Inventory rose 99.74% to -$3,000 in Q4 2019 from the same period last year, while for Dec 2019 it was -$605,000, marking a year-over-year change of. This contributed to the annual value of -$605,000 for FY2019, which is 493.14% down from last year.
  • Aclaris Therapeutics' Change in Inventory amounted to -$605,000 in FY2019, which was down 493.14% from -$102,000 recorded in FY2018.
  • In the past 5 years, Aclaris Therapeutics' Change in Inventory registered a high of -$102,000 during FY2018, and its lowest value of -$605,000 during FY2019.
  • Moreover, its 2-year median value for Change in Inventory was -$353,500 (2018), whereas its average is -$353,500.
  • Data for Aclaris Therapeutics' Change in Inventory shows a maximum YoY slumped of 493.14% (in 2019) over the last 5 years.
  • Aclaris Therapeutics' Change in Inventory (Yearly) stood at -$102,000 in 2018, then slumped by 493.14% to -$605,000 in 2019.